Selecting dopamine depleters for hyperkinetic movement disorders: how do we choose?

被引：2

作者：

Szpisjak, Laszlo ^{[1
]}

Salamon, Andras ^{[1
]}

Zadori, Denes ^{[1
]}

Klivenyi, Peter ^{[1
]}

Vecsei, Laszlo ^{[1
,2
,3
]}

机构：

[1] Univ Szeged, Albert Szent Gyorgyi Clin Ctr, Dept Neurol, Fac Med, Szeged, Hungary

[2] MTA SZTE Neurosci Res Grp, Szeged, Hungary

[3] Univ Szeged, Interdisciplinary Excellence Ctr, Dept Neurol, Szeged, Hungary

来源：

EXPERT OPINION ON PHARMACOTHERAPY | 2020年 / 21卷 / 01期

关键词：

Deutetrabenazine; hyperkinetic; movement disorders; tetrabenazine; valbenazine; VMAT2; inhibitor; TARDIVE-DYSKINESIA; DOUBLE-BLIND; TETRABENAZINE; DEUTETRABENAZINE;

D O I：

10.1080/14656566.2019.1685980

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1 / 4

页数：4

共 50 条

[1] Dopamine depleters in the treatment of hyperkinetic movement disorders
Jankovic, Joseph
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (18) : 2461 - 2470
[2] How Do We Choose?
Fuller, William
[J]. DOWN BEAT, 2024, 91 (03): : 10 - 10
[3] HOW DO WE CHOOSE?
Borland, Ron
[J]. ADDICTION, 2010, 105 (11) : 1894 - 1895
[4] How we choose the words we do
Buchanan, M
[J]. NEW SCIENTIST, 2005, 188 (2521) : 16 - 16
[5] How do we make mistakes diagnosing movement disorders?
Rosales, J.
Larripa, N.
Del Carpio, C. A.
Rodriguez-Quiroga, S. A.
Assante, L.
Cassen, J.
Arakaki, T.
Garretto, N. S.
[J]. MOVEMENT DISORDERS, 2016, 31 : S497 - S497
[6] HOW DO WE CHOOSE OUR MATE
COOKE, F
[J]. NEW SCIENTIST, 1979, 81 (1140) : 525 - 527
[7] HOW DO WE CHOOSE - TUCK,M
LEADER, R
[J]. JOURNAL OF THE MARKET RESEARCH SOCIETY, 1977, 19 (04): : 189 - 191
[8] Multiple vaccines: How do we choose?
Minkoff, Neil B.
[J]. JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (07): : S16 - S20
[9] Choosing wisely: how wisely do we choose?
Truskett, Philip
Slater, Kellee
[J]. ANZ JOURNAL OF SURGERY, 2022, 92 (10) : 2406 - 2407
[10] FLAMES, FURNACES, PLASMAS - HOW DO WE CHOOSE
SLAVIN, W
[J]. ANALYTICAL CHEMISTRY, 1986, 58 (04) : A589 - &

← 1 2 3 4 5 →